{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T10:50:19Z","timestamp":1775472619207,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["U54GM128729"],"award-info":[{"award-number":["U54GM128729"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["U54 GM115458"],"award-info":[{"award-number":["U54 GM115458"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["1R03CA223935-01"],"award-info":[{"award-number":["1R03CA223935-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A high-throughput drug screen revealed that veratridine (VTD), a natural plant alkaloid, induces expression of the anti-cancer protein UBXN2A in colon cancer cells. UBXN2A suppresses mortalin, a heat shock protein, with dominant roles in cancer development including epithelial\u2013mesenchymal transition (EMT), cancer cell stemness, drug resistance, and apoptosis. VTD-dependent expression of UBXN2A leads to the deactivation of mortalin in colon cancer cells, making VTD a potential targeted therapy in malignant tumors with high levels of mortalin. VTD was used clinically for the treatment of hypertension in decades past. However, the discovery of newer antihypertensive drugs and concerns over potential neuro- and cardiotoxicity ended the use of VTD for this purpose. The current study aims to determine the safety and efficacy of VTD at doses sufficient to induce UBXN2A expression in a mouse model. A set of flow-cytometry experiments confirmed that VTD induces both early and late apoptosis in a dose-dependent manner. In vivo intraperitoneal (IP) administration of VTD at 0.1\u2009mg\/kg every other day (QOD) for 4 weeks effectively induced expression of UBXN2A in the small and large intestines of mice. Liquid chromatography\u2013tandem mass spectrometry (LC\u2013MS\/MS) assays on tissues collected from VTD-treated animals demonstrated VTD concentrations in the low pg\/mg range. To address concerns regarding neuro- and cardiotoxicity, a comprehensive set of behavioral and cardiovascular assessments performed on C57BL\/6NHsd mice revealed that VTD generates no detectable neurotoxicity or cardiotoxicity in animals receiving 0.1\u2009mg\/kg VTD QOD for 30 days. Finally, mouse xenograft experiments in athymic nude mice showed that VTD can suppress tumor growth. The main causes for the failure of experimental oncologic drug candidates are lack of sufficient safety and efficacy. The results achieved in this study support the potential utility of VTD as a safe and efficacious anti-cancer molecule.<\/jats:p>","DOI":"10.1038\/s41420-022-00936-3","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T19:02:48Z","timestamp":1648494168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pre-clinical safety and therapeutic efficacy of a plant-based alkaloid in a human colon cancer xenograft model"],"prefix":"10.1038","volume":"8","author":[{"given":"Jessica L.","family":"Freeling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie L.","family":"Scholl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Eikanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cole","family":"Knoblich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashaun A.","family":"Potts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph E.","family":"Rower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7765-6970","authenticated-orcid":false,"given":"Mohammad Hadi","family":"Farjoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2315-8452","authenticated-orcid":false,"given":"Haotian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Pillatzki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1963-2211","authenticated-orcid":false,"given":"Khosrow","family":"Rezvani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"key":"936_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5114\/pg.2018.81072","volume":"14","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Gastroenterol Rev. 2019;14:89\u2013103.","journal-title":"Gastroenterol Rev"},{"key":"936_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. Ca Cancer J Clin. 2021;71:7\u201333.","journal-title":"Ca Cancer J Clin"},{"key":"936_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.21037\/jgo.2018.04.08","volume":"9","author":"AE Chambers","year":"2018","unstructured":"Chambers AE, Frick J, Tanner N, Gerkin R, Kundranda M, Dragovich T. Chemotherapy re-challenge response rate in metastatic colorectal cancer. J Gastrointest Oncol. 2018;9:679\u201386.","journal-title":"J Gastrointest Oncol"},{"key":"936_CR4","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1002\/1878-0261.12372","volume":"12","author":"S Sane","year":"2018","unstructured":"Sane S, Hafner A, Srinivasan R, Masood D, Slunecka JL, Noldner CJ, et al. UBXN2A enhances CHIP\u2010mediated proteasomal degradation of oncoprotein mortalin\u20102 in cancer cells. Mol Oncol. 2018;12:1753\u201377.","journal-title":"Mol Oncol"},{"key":"936_CR5","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/iub.2176","volume":"72","author":"M Xu","year":"2020","unstructured":"Xu M, Zhang Y, Cui M, Wang X, Lin Z. Mortalin contributes to colorectal cancer by promoting proliferation and epithelial\u2013mesenchymal transition. IUBMB Life. 2020;72:771\u201381.","journal-title":"IUBMB Life"},{"key":"936_CR6","doi-asserted-by":"publisher","first-page":"23561","DOI":"10.18632\/oncotarget.4452","volume":"6","author":"A Abdullah","year":"2015","unstructured":"Abdullah A, Sane S, Branick KA, Freeling JL, Wang H, Zhang D, et al. A plant alkaloid, veratridine, potentiates cancer chemosensitivity by UBXN2A-dependent inhibition of an oncoprotein, mortalin-2. Oncotarget 2015;6:23561\u201381.","journal-title":"Oncotarget"},{"key":"936_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/path.1672","volume":"205","author":"SR Dundas","year":"2005","unstructured":"Dundas SR, Lawrie LC, Rooney PH, Murray GI. Mortalin is over\u2010expressed by colorectal adenocarcinomas and correlates with poor survival. J Pathol. 2005;205:74\u201381.","journal-title":"J Pathol"},{"key":"936_CR8","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1023\/A:1008336904585","volume":"10","author":"DJ Propper","year":"1999","unstructured":"Propper DJ, Braybrooke JP, Taylor DJ, Lodi R, Styles P, Cramer JA, et al. Phase I trial of the selective mitochondrial toxin MKT 077 in chemo-resistant solid tumours. Ann Oncol. 1999;10:923\u20137.","journal-title":"Ann Oncol"},{"key":"936_CR9","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/j.1471-4159.1993.tb03592.x","volume":"61","author":"Z Deri","year":"1993","unstructured":"Deri Z, Adam\u2010Vizi V. Detection of intracellular free Na+ concentration of synaptosomes by a fluorescent indicator, Na+\u2010binding benzofuran isophthalate: the effect of veratridine, ouabain, and \u03b1\u2010latrotoxin. J Neurochem. 1993;61:818\u201325.","journal-title":"J Neurochem"},{"key":"936_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1113\/jphysiol.1997.sp021951","volume":"499","author":"CR Rose","year":"1997","unstructured":"Rose CR, Ransom BR. Regulation of intracellular sodium in cultured rat hippocampal neurones. J Physiol 1997;499:573\u201387.","journal-title":"J Physiol"},{"key":"936_CR11","first-page":"525","volume":"36","author":"PJ Pauwels","year":"1989","unstructured":"Pauwels PJ, Assouw HPV, Leysen JE, Janssen PA. Ca2+-mediated neuronal death in rat brain neuronal cultures by veratridine: protection by flunarizine. Mol Pharm. 1989;36:525\u201331.","journal-title":"Mol Pharm"},{"key":"936_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0304-3940(94)90053-1","volume":"177","author":"C Malgouris","year":"1994","unstructured":"Malgouris C, Daniel M, Doble A. Neuroprotective effects of riluzole on N-methyl-d-aspartate- or veratridine-induced neurotoxicity in rat hippocampal slices. Neurosci Lett. 1994;177:95\u20139.","journal-title":"Neurosci Lett"},{"key":"936_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1742-7843.2006.pto_339.x","volume":"98","author":"SA Otoom","year":"2006","unstructured":"Otoom SA, Handu SS, Wazir JF, James H, Sharma PR, Hasan ZA, et al. Veratridine\u2010induced wet dog shake behaviour and apoptosis in rat hippocampus. Basic Clin Pharm. 2006;98:423\u20136.","journal-title":"Basic Clin Pharm"},{"key":"936_CR14","first-page":"1117","volume":"255","author":"PJ Pauwels","year":"1990","unstructured":"Pauwels PJ, Assouw HPV, Peeters L, Leysen JE. Neurotoxic action of veratridine in rat brain neuronal cultures: mechanism of neuroprotection by Ca++ antagonists nonselective for slow Ca++ channels. J Pharm Exp Ther. 1990;255:1117\u201322.","journal-title":"J Pharm Exp Ther"},{"key":"936_CR15","doi-asserted-by":"crossref","unstructured":"Wermelskirchen D, Gleitz J, Urenjak J, Wilffert B, Tegtmeier F, Peters Th.Flunarizine and R 56865 suppress veratridine-induced increase in oxygen consumption and uptake of 45Ca2+ in rat cortical synaptosomes. Neuropharmacology. 1992;31:235\u201341.","DOI":"10.1016\/0028-3908(92)90173-M"},{"key":"936_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0014-2999(92)90303-L","volume":"219","author":"D Wermelskirchen","year":"1992","unstructured":"Wermelskirchen D, Wilffert B, Nebel U, Leidig A, Wirth A, Peters T. Veratridine activates a silent sodium channel in rat isolated aorta. Eur J Pharm. 1992;219:253\u20139.","journal-title":"Eur J Pharm"},{"key":"936_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17:395\u2013417.","journal-title":"Nat Rev Clin Oncol"},{"key":"936_CR18","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2174\/1389200219666180511154722","volume":"19","author":"Y Wang","year":"2018","unstructured":"Wang Y, Zhong J, Bai J, Tong R, An F, Jiao P, et al. The application of natural products in cancer therapy by targeting apoptosis pathways. Curr Drug Metab. 2018;19:739\u201349.","journal-title":"Curr Drug Metab"},{"key":"936_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2174\/1568026613666131216105049","volume":"14","author":"P Kittakoop","year":"2013","unstructured":"Kittakoop P, Mahidol C, Ruchirawat S. Alkaloids as important scaffolds in therapeutic drugs for the treatments of cancer, tuberculosis, and smoking cessation. Curr Top Med Chem2013;14:239\u201352.","journal-title":"Curr Top Med Chem"},{"key":"936_CR20","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1038\/s41401-018-0065-z","volume":"39","author":"X Zhang","year":"2018","unstructured":"Zhang X, Bi R, Zhang P, Gan Y. Veratridine modifies the gating of human voltage-gated sodium channel Nav1.7. Acta Pharm Sin. 2018;39:1716\u201324.","journal-title":"Acta Pharm Sin"},{"key":"936_CR21","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/sj.bjp.0703451","volume":"130","author":"J Jord\u00e1n","year":"2000","unstructured":"Jord\u00e1n J, Galindo MF, Calvo S, Gonz\u00e1lez\u2010Garc\u00eda C, Ce\u00f1a V. Veratridine induces apoptotic death in bovine chromaffin cells through superoxide production. Br J Pharm. 2000;130:1496\u2013504.","journal-title":"Br J Pharm"},{"key":"936_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jneumeth.2004.02.004","volume":"137","author":"T Weiser","year":"2004","unstructured":"Weiser T. A novel toxicity-based assay for the identification of modulators of voltage-gated Na+ channels. J Neurosci Methods. 2004;137:79\u201385.","journal-title":"J Neurosci Methods"},{"key":"936_CR23","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3181\/00379727-76-18651","volume":"76","author":"ED Swiss","year":"1951","unstructured":"Swiss ED, Bauer RO. Acute toxicity of veratrum derivatives.\u2217. Proc Soc Exp Biol Med. 1951;76:847\u20139.","journal-title":"Proc Soc Exp Biol Med"},{"key":"936_CR24","first-page":"89","volume":"113","author":"K Tanaka","year":"1955","unstructured":"Tanaka K. Studies on Veratrum alkaloids. XX. Actions of Veratrum alkaloids upon the central nervous system of mice. J Pharm Exp Ther. 1955;113:89\u201399.","journal-title":"J Pharm Exp Ther"},{"key":"936_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1161\/01.CIR.1.2.204","volume":"1","author":"E Meilman","year":"1950","unstructured":"Meilman E, Krayer O. Clinical studies on Veratrum alkaloids. Circulation 1950;1:204\u201313.","journal-title":"Circulation"},{"key":"936_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.4103\/1947-2714.100998","volume":"4","author":"T Mahmood","year":"2012","unstructured":"Mahmood T, Yang P-C. Western Blot: technique, theory, and trouble shooting. North Am J Med Sci. 2012;4:429\u201334.","journal-title":"North Am J Med Sci"},{"key":"936_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1513\/pats.200409-049TA","volume":"1","author":"JS Patton","year":"2004","unstructured":"Patton JS, Fishburn CS, Weers JG. The lungs as a portal of entry for systemic drug delivery. Proc Am Thorac Soc. 2004;1:338\u201344.","journal-title":"Proc Am Thorac Soc"},{"key":"936_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jchromb.2008.11.041","volume":"877","author":"X Ye","year":"2009","unstructured":"Ye X, Wang Y, Yang M, Wang Q, Liang Q, Ma Z, et al. Investigating the in vitro metabolism of veratridine: characterization of metabolites and involved cytochrome P450 isoforms. J Chromatogr B. 2009;877:141\u20138.","journal-title":"J Chromatogr B"},{"key":"936_CR29","doi-asserted-by":"publisher","first-page":"112670","DOI":"10.1016\/j.physbeh.2019.112670","volume":"211","author":"JL Scholl","year":"2019","unstructured":"Scholl JL, Afzal A, Fox LC, Watt MJ, Forster GL. Sex differences in anxiety-like behaviors in rats. Physiol Behav. 2019;211:112670.","journal-title":"Physiol Behav"},{"key":"936_CR30","doi-asserted-by":"publisher","first-page":"e1118","DOI":"10.1038\/cddis.2014.100","volume":"5","author":"S Sane","year":"2014","unstructured":"Sane S, Abdullah A, Boudreau DA, Autenried RK, Gupta BK, Wang X, et al. Ubiquitin-like (UBX)-domain-containing protein, UBXN2A, promotes cell death by interfering with the p53\u2013Mortalin interactions in colon cancer cells. Cell Death Dis. 2014;5:e1118\u2013e1118.","journal-title":"Cell Death Dis"},{"key":"936_CR31","first-page":"5","volume":"31","author":"BA Weinberg","year":"2017","unstructured":"Weinberg BA, Marshall JL, Salem ME. The growing challenge of young adults with colorectal cancer. Oncology 2017;31:5.","journal-title":"Oncology"},{"key":"936_CR32","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.2174\/0929867323666160627105033","volume":"23","author":"JD Black","year":"2016","unstructured":"Black JD, Rezvani K. Heat shock protein 70s as potential molecular targets for colon cancer therapeutics. Curr Med Chem. 2016;23:3171\u201388.","journal-title":"Curr Med Chem"},{"key":"936_CR33","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/cdd.2010.177","volume":"18","author":"W-J Lu","year":"2011","unstructured":"Lu W-J, Lee NP, Kaul SC, Lan F, Poon RTP, Wadhwa R, et al. Mortalin\u2013p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy. Cell Death Differ. 2011;18:1046\u201356.","journal-title":"Cell Death Differ"},{"key":"936_CR34","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3892\/ijo.2013.2161","volume":"44","author":"J Chen","year":"2013","unstructured":"Chen J, Liu W-B, Jia W-D, Xu G-L, Ma J-L, Huang M, et al. Overexpression of Mortalin in hepatocellular carcinoma and its relationship with angiogenesis and epithelial to mesenchymal transition. Int J Oncol. 2013;44:247\u201355.","journal-title":"Int J Oncol."},{"key":"936_CR35","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/ijc.28029","volume":"133","author":"P Rozenberg","year":"2013","unstructured":"Rozenberg P, Kocsis J, Saar M, Proh\u00e1szka Z, F\u00fcst G, Fishelson Z. Elevated levels of mitochondrial mortalin and cytosolic HSP70 in blood as risk factors in patients with colorectal cancer. Int J Cancer. 2013;133:514\u20138.","journal-title":"Int J Cancer"},{"key":"936_CR36","doi-asserted-by":"publisher","first-page":"29586","DOI":"10.1074\/jbc.273.45.29586","volume":"273","author":"R Wadhwa","year":"1998","unstructured":"Wadhwa R, Takano S, Robert M, Yoshida A, Nomura H, Reddel RR, et al. Inactivation of tumor suppressor p53 by Mot-2, a hsp70 family member*. J Biol Chem. 1998;273:29586\u201391.","journal-title":"J Biol Chem"},{"key":"936_CR37","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/cancers13040835","volume":"13","author":"AN Sari","year":"2021","unstructured":"Sari AN, Elwakeel A, Dhanjal JK, Kumar V, Sundar D, Kaul SC, et al. Identification and characterization of MortaparibPlus\u2014a novel triazole derivative that targets mortalin\u2013p53 interaction and inhibits cancer-cell proliferation by wild-type p53-dependent and -independent mechanisms. Cancers 2021;13:835.","journal-title":"Cancers"},{"key":"936_CR38","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.biocel.2011.11.021","volume":"44","author":"A Grover","year":"2012","unstructured":"Grover A, Priyandoko D, Gao R, Shandilya A, Widodo N, Bisaria VS, et al. Withanone binds to mortalin and abrogates mortalin\u2013p53 complex: computational and experimental evidence. Int J Biochem Cell Biol. 2012;44:496\u2013504.","journal-title":"Int J Biochem Cell Biol"},{"key":"936_CR39","first-page":"538","volume":"56","author":"K Koya","year":"1996","unstructured":"Koya K, Li Y, Wang H, Ukai T, Tatsuta N, Kawakami M, et al. MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation. Cancer Res. 1996;56:538\u201343.","journal-title":"Cancer Res"},{"key":"936_CR40","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000356436","volume":"41","author":"C-H K\u00f6hne","year":"2014","unstructured":"K\u00f6hne C-H. Successes and limitations of targeted cancer therapy in colon cancer. Prog Tumor Res 2014;41:36\u201350.","journal-title":"Prog Tumor Res"},{"key":"936_CR41","first-page":"1231","volume":"4","author":"M Moudi","year":"2013","unstructured":"Moudi M, Go R, Yien CYS, Nazre M. Vinca alkaloids. Int J Prev Med 2013;4:1231\u20135.","journal-title":"Int J Prev Med"},{"key":"936_CR42","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1517\/14740338.2011.581660","volume":"10","author":"FA Schutz","year":"2011","unstructured":"Schutz FA, Bellmunt J, Rosenberg JE, Choueiri TK. Vinflunine: drug safety evaluation of this novel synthetic vinca alkaloid. Expert Opin Drug Saf. 2011;10:645\u201353.","journal-title":"Expert Opin Drug Saf"},{"key":"936_CR43","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ejmech.2019.05.027","volume":"176","author":"A Kumar","year":"2019","unstructured":"Kumar A, Jaitak V. Natural products as multidrug resistance modulators in cancer. Eur J Med Chem. 2019;176:268\u201391.","journal-title":"Eur J Med Chem"},{"key":"936_CR44","doi-asserted-by":"publisher","first-page":"109142","DOI":"10.1016\/j.biopha.2019.109142","volume":"117","author":"X Huang","year":"2019","unstructured":"Huang X, Yang Z, Xie Q, Zhang Z, Zhang H, Ma J. Natural products for treating colorectal cancer: a mechanistic review. Biomed Pharmacother 2019;117:109142.","journal-title":"Biomed Pharmacother"},{"key":"936_CR45","doi-asserted-by":"publisher","first-page":"5410","DOI":"10.2174\/0929867325666180713155702","volume":"26","author":"S Olgen","year":"2019","unstructured":"Olgen S, Kotra LP. Drug repurposing in the development of anticancer agents. Curr Med Chem. 2019;26:5410\u201327.","journal-title":"Curr Med Chem"},{"key":"936_CR46","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1002\/ijc.30918","volume":"141","author":"R Jubran","year":"2017","unstructured":"Jubran R, Kocsis J, Garam N, Mal\u00e1ti \u00c9, Gombos T, Barab\u00e1s L, et al. Circulating mitochondrial stress 70 protein\/mortalin and cytosolic Hsp70 in blood: risk indicators in colorectal cancer. Int J Cancer. 2017;141:2329\u201335.","journal-title":"Int J Cancer"},{"key":"936_CR47","doi-asserted-by":"publisher","first-page":"104593","DOI":"10.1016\/j.yexmp.2020.104593","volume":"118","author":"R Zhang","year":"2021","unstructured":"Zhang R, Meng Z, Wu X, Zhang M, Zhang S, Jin T. Mortalin promotes breast cancer malignancy. Exp Mol Pathol. 2021;118:104593.","journal-title":"Exp Mol Pathol"},{"key":"936_CR48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.anndiagpath.2019.06.011","volume":"42","author":"W Cheng","year":"2019","unstructured":"Cheng W, Zhang B, Zikeliyar M, Wang J, Jian H, Wu K, et al. Elevated Mortalin correlates with poor outcome in hepatocellular carcinoma. Ann Diagn Pathol. 2019;42:59\u201363.","journal-title":"Ann Diagn Pathol"},{"key":"936_CR49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.gene.2019.02.033","volume":"696","author":"M Xu","year":"2019","unstructured":"Xu M, Jin T, Chen L, Zhang X, Zhu G, Wang Q, et al. Mortalin is a distinct bio-marker and prognostic factor in serous ovarian carcinoma. Gene 2019;696:63\u201371.","journal-title":"Gene"},{"key":"936_CR50","doi-asserted-by":"publisher","first-page":"16070","DOI":"10.1038\/mtm.2016.70","volume":"3","author":"JL Freeling","year":"2016","unstructured":"Freeling JL, Rezvani K. Assessment of murine colorectal cancer by micro-ultrasound using three dimensional reconstruction and non-linear contrast imaging. Mol Ther-Methods Clin Dev. 2016;3:16070.","journal-title":"Mol Ther-Methods Clin Dev"},{"key":"936_CR51","doi-asserted-by":"publisher","first-page":"e11500","DOI":"10.7717\/peerj.11500","volume":"9","author":"NT Thielen","year":"2021","unstructured":"Thielen NT, Kleinsasser AA, Freeling JL. Myocardial contrast echocardiography assessment of mouse myocardial infarction: comparison of kinetic parameters with conventional methods. Peerj 2021;9:e11500.","journal-title":"Peerj"},{"key":"936_CR52","doi-asserted-by":"publisher","first-page":"108029","DOI":"10.1016\/j.drugalcdep.2020.108029","volume":"212","author":"JL Freeling","year":"2020","unstructured":"Freeling JL, McFadden LM. The emergence of cardiac changes following the self-administration of methamphetamine. Drug Alcohol Depend. 2020;212:108029.","journal-title":"Drug Alcohol Depend"},{"key":"936_CR53","doi-asserted-by":"publisher","first-page":"102624","DOI":"10.1016\/j.autneu.2019.102624","volume":"223","author":"DS Martin","year":"2019","unstructured":"Martin DS, Vogel E, Freeling J, Reihe C. Activation of bradykinin-sensitive pericardial afferents increases systemic venous tone in conscious rats. Auton Neurosci. 2019;223:102624.","journal-title":"Auton Neurosci"},{"key":"936_CR54","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1111\/ejn.14019","volume":"48","author":"MA Weber","year":"2018","unstructured":"Weber MA, Graack ET, Scholl JL, Renner KJ, Forster GL, Watt MJ. Enhanced dopamine D2 autoreceptor function in the adult prefrontal cortex contributes to dopamine hypoactivity following adolescent social stress. Eur J Neurosci 2018;48:1833\u201350.","journal-title":"Eur J Neurosci"},{"key":"936_CR55","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3389\/fnins.2017.00608","volume":"11","author":"N Vinzant","year":"2017","unstructured":"Vinzant N, Scholl JL, Wu C-M, Kindle T, Koodali R, Forster GL. Iron oxide nanoparticle delivery of peptides to the brain: reversal of anxiety during drug withdrawal. Front Neurosci. 2017;11:608.","journal-title":"Front Neurosci"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-00936-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-00936-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-00936-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T15:19:02Z","timestamp":1669303142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-00936-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["936"],"URL":"https:\/\/doi.org\/10.1038\/s41420-022-00936-3","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,28]]},"assertion":[{"value":"23 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}